Understanding Suboxone: What Does Suboxone Do and Who Should Use It?
Drug overdose deaths in the United States exceeded 107,000 in 2021, with 80,816 involving opioids. This crisis just needs effective treatment options. So, what does Suboxone do to address opioid dependence? Suboxone is a prescription medication that combines buprenorphine and naloxone. It’s designed to treat opioid use disorder. Medication-Assisted Treatment (MOUD) using Suboxone has been shown to lower the risk of fatal overdoses by approximately 50%.
Anyone who is thinking over treatment should know how Suboxone works and what it does for you. This piece will explain Suboxone’s components and how it interacts with your brain. You’ll learn who should use it, what to expect during treatment, and the benefits and risks you need to know.
What Is Suboxone and How Does Suboxone Work
Buprenorphine: The Partial Opioid Agonist Component
Suboxone contains two active ingredients: buprenorphine and naloxone, combined in a 4:1 ratio. Buprenorphine functions as a partial agonist at the mu-opioid receptor. It binds to these receptors and activates them without producing the full effects of traditional opioids. This partial activation relieves withdrawal symptoms and reduces cravings while limiting euphoric effects.
The partial agonist properties create a ceiling effect. Increasing doses beyond a certain point produce no additional opioid effects. Buprenorphine exhibits high-affinity binding to mu-opioid receptors with slow dissociation kinetics. This characteristic allows it to displace full agonists like heroin and methadone from receptors while blocking their effects. Buprenorphine demonstrates potency 20 times greater than morphine at analgesic doses, yet its ceiling effect reduces fatal respiratory depression risk by a lot compared to full agonists.
Naloxone: The Misuse Prevention Component
Naloxone, an opioid antagonist, serves as a deterrent against misuse through injection or intranasal routes. Naloxone remains mostly inactive when taken sublingually as prescribed due to limited bioavailability of less than 10%. But if dissolved and injected intravenously, the absorbed naloxone blocks mu receptors and counteracts buprenorphine’s euphoric effects. This can induce withdrawal in opioid-dependent individuals.
How Suboxone Interacts with Brain Receptors
Buprenorphine binds with very high affinity to mu-opioid receptors throughout your brain’s limbic system, spinal cord and gastrointestinal tract. A dose of 4 mg per day binds about 50% of mu-opioid receptors, sufficient to suppress withdrawal symptoms. Buprenorphine occupies about 80% of these receptors at 16 mg and blocks the euphoric effects of most abused opioids. Buprenorphine also acts as a kappa-opioid receptor antagonist, which helps reduce dysphoric effects and stress responses.
Sublingual Administration and Absorption
The sublingual route will give rapid absorption while circumventing first-pass metabolism. Bioavailability of sublingually administered buprenorphine reaches about 30%. Peak plasma concentrations occur between 40 and 210 minutes after administration. Buprenorphine reaches peak levels at 0.75 to 1.0 hours and naloxone at 0.5 hours. You must place the film under your tongue until it dissolves to achieve proper absorption.
Who Should Use Suboxone: Ideal Candidates for Treatment
People with Opioid Use Disorder Seeking Recovery
Suboxone is prescribed specifically to treat opioid dependence with substances such as heroin, morphine, fentanyl, oxycodone and hydrocodone. You must meet the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for opioid use disorder to qualify for treatment. The Substance Abuse and Mental Health Services Administration identifies core requirements: you must have no contraindications to buprenorphine or naloxone, commit to complying with treatment protocols, understand both benefits and risks, and follow safety precautions.
You need to accept treatment. Without your willingness to enter treatment and maintain scheduled physician visits, understand what Suboxone does for you becomes irrelevant. Adults and children over 15 can safely use Suboxone when combined with medical, social and psychological support.
Patients Who Have Failed Other Treatment Methods
Buprenorphine serves as an effective option for patients with contraindications to methadone or when methadone facilities remain unavailable. Suboxone offers an alternative path if you face a waitlist exceeding three months for methadone enrollment. Patients who experienced treatment failure with methadone or demonstrate intolerance to it may benefit from buprenorphine therapy. Those with brief opioid dependence history or lower opioid agonist requirements respond well to this treatment approach.
Those Needing Long-Term Maintenance Support
Most patients require long-term treatment, with duration extending indefinitely. Research comparing buprenorphine taper versus maintenance revealed differences: only 11% of patients in the taper group completed treatment, compared to 66% in the maintenance group. Five years after original medication-assisted treatment, approximately 50% of patients prescribed buprenorphine achieved abstinence. Keep in mind that discontinuing opioid agonist therapy increases death risk by more than three times.
When Suboxone Is Not Recommended
Certain conditions require monitoring or preclude Suboxone use:
- Hypersensitivity or allergic reactions to buprenorphine or naloxone
- Severe respiratory problems or sleep apnea
- Severe liver disease (Child-Pugh score 10-15)
- Active psychosis or suicidal ideation
- Current high-dose benzodiazepine or alcohol dependence
- Pregnancy requires careful risk-benefit discussion with healthcare providers
Pregnant women face particular considerations, as Suboxone use during pregnancy may cause neonatal opioid withdrawal syndrome. But the FDA urges caution about withholding treatment, noting that the harm of untreated opioid use disorder often outweighs combination therapy risks.
What to Expect During Suboxone Treatment
Original Induction Phase and Timing Requirements
Treatment begins only when you show objective signs of withdrawal. You must wait 12-24 hours after your last use for short-acting opioids like heroin, hydrocodone, or Percocet. Long-acting opioids require longer abstinence: 36 hours for Oxycontin or morphine and more than 48 hours for methadone[142]. Your Clinical Opioid Withdrawal Scale (COWS) score should exceed 12 before receiving your first dose. Starting too early risks precipitated withdrawal, where buprenorphine displaces other opioids from receptors and triggers intense symptoms.
Day 1 brings up to 8 mg/2 mg buprenorphine/naloxone in divided doses. Day 2 increases to up to 16 mg/4 mg as a single dose[152]. Your provider monitors your response during these critical first days.
Stabilization and Maintenance Dosage
Day 3 onwards brings dose adjustments in increments of 2 mg/0.5 mg or 4 mg/1 mg until withdrawal symptoms and cravings are suppressed[152]. Maintenance dosages range from 4 mg/1 mg to 24 mg/6 mg daily[152]. The recommended target dose is 16 mg/4 mg, though patients prescribed 24 mg showed 20% greater likelihood of remaining in treatment over 180 days. Approximately 80% of opioid receptors are occupied at 16 mg.
Combining Suboxone with Counseling and Behavioral Therapy
Suboxone must be used as part of a complete treatment plan that includes counseling and psychosocial support[152]. Despite this requirement, 73.8% of patients receive no therapy services. Another 17.2% receive low-intensity therapy and 9.0% receive high-intensity therapy. Patients receiving therapy demonstrate substantially lower discontinuation rates.
Treatment Duration and Tapering Considerations
No maximum treatment duration exists. You may require medication indefinitely. Gradual tapering reduces withdrawal occurrence when discontinuing[152]. But tapering carries relapse risk, as discontinuing opioid agonist therapy increases death risk more than three times.
Benefits, Risks, and Side Effects of Suboxone
Main Benefits: Reduced Cravings and Withdrawal Symptoms
Suboxone reduces withdrawal symptoms that include anxiety, nausea, muscle aches, insomnia, and sweating. Clinical trials showed its effectiveness in keeping people with opioid dependence in treatment for extended periods, with notable improvement over 24 weeks. The ceiling effect on opioid impact reduces overdose risk. Deaths from overdose decreased by 50% when used in addiction treatment.
Common Side Effects to Monitor
Common side effects include headache, nausea, vomiting, constipation, increased sweating, and insomnia. Sublingual formulations may cause oral hypoesthesia (numbness), glossodynia (tongue pain), and oral mucosal erythema (redness). You may also experience dizziness, drowsiness, coordination problems, and peripheral edema. Rare cases involve dental caries or tooth loss.
Serious Risks: Respiratory Depression and Drug Interactions
Suboxone can cause life-threatening respiratory depression, especially when you have combined it with other opioid medicines, benzodiazepines, alcohol, or central nervous system depressants[281]. There are 745 known drug interactions with Suboxone. These include 212 major interactions. Liver problems may occur and show as jaundice, dark urine, or upper abdominal pain.
Precautions with Alcohol and Benzodiazepines
Combining Suboxone with benzodiazepines triples your risk of fatal overdose. Research shows 82% of buprenorphine-related deaths involved benzodiazepines, and 31% of fatal opioid overdoses during buprenorphine treatment occurred with concurrent benzodiazepine use. Alcohol lowers the threshold for fatal buprenorphine overdose levels. This can lead to hypotension, respiratory depression, profound sedation, and coma.
Physical Dependence and Withdrawal Management
Chronic administration produces opioid-type physical dependence. Abrupt discontinuation triggers withdrawal symptoms that are most intense in the first 72 hours. These include nausea, vomiting, muscle aches, insomnia, anxiety, and fever. Symptoms subside to body aches and mood swings after one week. Depression becomes prominent after two weeks, with intense cravings and depression persisting after one month.
Suboxone Can Be a Path to Recovery
Suboxone offers a proven path to recovery for opioid use disorder. This medication combines buprenorphine and naloxone to reduce cravings and withdrawal symptoms while cutting overdose deaths by half. Treatment success depends on proper medical supervision and appropriate timing, along with commitment to counseling support. Many patients require extended therapy to sustain recovery when it comes to long-term maintenance. What Suboxone can accomplish for your trip toward lasting sobriety ended up being determined by your willingness to follow prescribed protocols and safety precautions.